ISSN: 0973-7510

E-ISSN: 2581-690X

Review Article | Open Access
Jagadish Kumar Suluvoy2, P. Levin Anbu Gomez1, T. Jesse Joel1 ,Neha Toppo1, Dhanu P. Karthikeyan1 and Ritu Shepherd3
1Department of Biotechnology, School of Agriculture and Biosciences, Karunya Institute of Technology and Sciences (Deemed to be University), Coimbatore – 641 114, Tamil Nadu, India.
2Department of Biotechnology, Vignan’s Foundation for Science, Technology and Research, Guntur – 522 213, Andhra Pradesh, India.
3PG and Research Department of English, Nehru Arts and Science College, Coimbatore – 641 105, Tamil Nadu, India.
J Pure Appl Microbiol. 2021;15(4):1809-1815 | Article Number: 7189
https://doi.org/10.22207/JPAM.15.4.67 | © The Author(s). 2021
Received: 18/07/2021 | Accepted: 02/11/2021 | Published: 24/11/2021
Abstract

The world is facing major issues related to antibiotic resistance, specific drugs targeting and its side effects. Such obstacles can be rectified by nanotechnology as they have essential characteristics with smaller size, target specificity, easy deliverable with lesser side effects. The prime nature of the nanoparticles are, it can probe into the cell wall of the pathogenic microbes and even have the capacity to intrude into cellular pathways. Nanoparticles themselves are capable of destroying unwanted foreign particles or toxic cells, which enter into our bodies. Nanoparticles can be treated as carriers, in which they combine with specific drugs and deliver to target specific cells with lesser side effects. Nanoparticles are used as a drug delivery agent for various kinds of diseases related to cancer. Nanoparticles with drugs increase the antibiotic release at the different target sites and these nanoparticles have a great tendency to deliver a large number of drugs to a cell. In this current review, we discuss the bright future of NPs as drug delivery agents as it can overcome all conventional problems.

Keywords

Nanoparticles, Drug delivery system, Antibiotics, Bacteria, Cancer

Article Metrics

Article View: 1800

Share This Article

© The Author(s) 2021. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.